Your shopping cart is currently empty

Wy 49051 is an orally active antagonist of H1 receptor(IC50 of 44 nM).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $106 | - | In Stock | |
| 5 mg | $209 | - | In Stock | |
| 10 mg | $303 | - | In Stock | |
| 25 mg | $475 | - | In Stock | |
| 50 mg | $638 | - | In Stock | |
| 100 mg | $826 | - | In Stock | |
| 200 mg | $1,100 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $230 | - | In Stock |
| Description | Wy 49051 is an orally active antagonist of H1 receptor(IC50 of 44 nM). |
| Targets&IC50 | H1 receptor:44 nM |
| In vitro | Wy 49051 showed a great inhibitory effect on H1. At a concentration of 100 nM, it produced 92% inhibition of histamine-induced guinea pig ileal contraction. Wy 49051 is the most effective compound, with 700 times the potency of astemizole and 470 times the potency of hydroquinone. Wy 49051 also has high affinity for α1 receptor with IC50 of 8 nM[1]. |
| In vivo | Wy 49051 demonstrates efficacy in counteracting histamine-induced lethality in guinea pigs, with effective doses (ED50) of 1.91 mg/kg orally (po), 0.70 mg/kg intraperitoneally (ip), and 0.01 mg/kg intravenously (iv). Additionally, the compound maintains its oral efficacy without any reduction for up to 18 hours posttreatment[1]. |
| Synonyms | Wy-49051 |
| Molecular Weight | 487.59 |
| Formula | C28H33N5O3 |
| Cas No. | 113418-56-7 |
| Smiles | C(CCN1CCC(OC(C2=CC=CC=C2)C3=CC=CC=C3)CC1)N4C5=C(N(C)C(=O)N(C)C5=O)N=C4 |
| Relative Density. | 1.25 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 45 mg/mL (92.29 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (10.25 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.